Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use HYQVIA® safely and effectively. See full prescribing information for HYQVIA. HYQVIA® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-other
HYQVIA is indicated for the treatment of Primary Immunodeficiency (PI) in adults and pediatric patients two years of age and older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. HYQVIA is indicated for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy to prevent relapse of neuromuscular disability and impairment in adults.
- generic_name
- immune globulin infusion (human), 10% with recombinant human hyaluronidase
- brand_name
- HUMAN IMMUNEGLOBULIN G, HYALURONIDASE (HUMAN RECOMBINANT)
- product_names
- Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase, HUMAN IMMUNEGLOBULIN G, HYALURONIDASE (HUMAN RECOMBINANT)
- ndc
- 0944-2510, 0944-2511, 0944-2512, 0944-2513, 0944-2514, 0944-2510-02, 0944-2715, 0944-2715-25, 0944-2720, 0944-2720-03, 0944-2511-02, 0944-2716, 0944-2716-05, 0944-2721, 0944-2721-03, 0944-2512-02, 0944-2717, 0944-2717-10, 0944-2722, 0944-2722-03, 0944-2513-02, 0944-2718, 0944-2718-20, 0944-2723, 0944-2723-03, 0944-2514-02, 0944-2719, 0944-2719-30, 0944-2724, 0944-2724-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en